Global Opioid-Induced Constipation Competitive Landscape Professional Research Report 2025

Global Opioid-Induced Constipation Competitive Landscape Professional Research Report 2025

Research Summary

Opioid-induced constipation (OIC) is a common and distressing side effect associated with the use of opioid medications for pain management. Opioids, which include prescription medications like morphine and oxycodone, as well as illicit drugs such as heroin, can slow down the digestive system and lead to infrequent, difficult, and painful bowel movements. OIC can cause significant discomfort, impact a person＇s quality of life, and, if left untreated, may result in serious complications such as bowel blockages. Healthcare providers often recommend various treatments, including lifestyle changes, dietary modifications, and specific medications, to alleviate OIC and improve the overall well-being of individuals on opioid therapy while ensuring effective pain management.

According to DIResearch's in-depth investigation and research, the global Opioid-Induced Constipation market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Opioid-Induced Constipation include Ironwood Pharmaceuticals, Daiichi Sankyo, Pfizer, Progenics Pharmaceuticals, Shionogi, Allergan, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma, Mundipharma International, Ono Pharmaceutical, Takeda Pharmaceutical Company, Theravance Biopharma, Bausch Health, Cosmo Pharmaceuticals, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Opioid-Induced Constipation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Opioid-Induced Constipation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Opioid-Induced Constipation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Opioid-Induced Constipation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Opioid-Induced Constipation Include:

Ironwood Pharmaceuticals

Daiichi Sankyo

Pfizer

Progenics Pharmaceuticals

Shionogi

Allergan

Nektar Therapeutics

Purdue Pharma

S.L.A. Pharma

Mundipharma International

Ono Pharmaceutical

Takeda Pharmaceutical Company

Theravance Biopharma

Bausch Health

Cosmo Pharmaceuticals

Daewoong Pharmaceutical

C.B. Fleet Company

Sucampo Pharmaceuticals

Opioid-Induced Constipation Product Segment Include:

Lubiprostone

Methylnaltrexone Bromide

Naldemedine

Alvimopan

Others

Opioid-Induced Constipation Product Application Include:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Opioid-Induced Constipation Industry PESTEL Analysis

Chapter 3: Global Opioid-Induced Constipation Industry Porter’s Five Forces Analysis

Chapter 4: Global Opioid-Induced Constipation Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Opioid-Induced Constipation Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Opioid-Induced Constipation Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources